Advocacy

Advocacy News

ASAM and OHSAM send letter to the State of Ohio Board of Pharmacy and the Department of Mental Health and Addiction Services asking them to provide education and clarity to providers of office-based opioid treatment on new proposed rules

February 2, 2017

PDF

 

ASAM and the Ohio Society of Addiction Medicine (OHSAM) sent a letter to the State of Ohio Board of Pharmacy and the Department of Mental Health and Addiction Services asking them to provide education and clarity to providers of office-based opioid treatment (OBOT) on new proposed rules.The new rules being proposed to regulate OBOT providers require owners and responsible persons at an OBOT location to obtain a category III license.